Hiramoto and colleagues examine the current status of interventions for peripheral artery disease, focusing on disease staging, treatment goals, and factors that influence outcomes. Persistent unmet needs and emerging approaches (including cell-based and gene-based therapies) are also highlighted.
- Jade S. Hiramoto
- Martin Teraa
- Michael S. Conte
